Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

75 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
An alternative analysis of illicit opioid use during treatment in a randomized trial of extended-release naltrexone versus buprenorphine-naloxone: A per-protocol and completers analysis.
Mitchell MM, Schwartz RP, Choo TH, Pavlicova M, O'Grady KE, Gryczynski J, Stitzer ML, Nunes EV, Rotrosen J. Mitchell MM, et al. Among authors: choo th. Drug Alcohol Depend. 2021 Feb 1;219:108422. doi: 10.1016/j.drugalcdep.2020.108422. Epub 2020 Dec 9. Drug Alcohol Depend. 2021. PMID: 33352487 Free PMC article. Clinical Trial.
Association between methadone or buprenorphine use during medically supervised opioid withdrawal and extended-release injectable naltrexone induction failure.
Shulman M, Choo TH, Scodes J, Pavlicova M, Wai J, Haenlein P, Tofighi B, Campbell ANC, Lee JD, Rotrosen J, Nunes EV. Shulman M, et al. Among authors: choo th. J Subst Abuse Treat. 2021 May;124:108292. doi: 10.1016/j.jsat.2021.108292. Epub 2021 Jan 16. J Subst Abuse Treat. 2021. PMID: 33771287 Free PMC article.
Durable Viral Suppression Among People with HIV and Problem Substance Use in the Era of Universal Antiretroviral Treatment.
Paschen-Wolff MM, Campbell ANC, Tross S, Choo TH, Pavlicova M, Braunstein S, Lazar R, Borges C, Castro M, Berg H, Harriman G, Remien RH, Des Jarlais D. Paschen-Wolff MM, et al. Among authors: choo th. AIDS Behav. 2022 Feb;26(2):385-396. doi: 10.1007/s10461-021-03392-9. Epub 2021 Jul 30. AIDS Behav. 2022. PMID: 34331177 Free PMC article.
Corrigendum to "Naturalistic follow-up after a trial of medications for opioid use disorder: Medication status, opioid use, and relapse" [Journal of Substance Abuse Treatment 131 (2021) 108447].
Greiner MG, Shulman M, Choo TH, Scodes J, Pavlicova M, Campbell ANC, Novo P, Fishman M, Lee JD, Rotrosen J, Nunes EV. Greiner MG, et al. Among authors: choo th. J Subst Abuse Treat. 2022 May;136:108566. doi: 10.1016/j.jsat.2021.108566. Epub 2021 Aug 6. J Subst Abuse Treat. 2022. PMID: 34366203 Free PMC article. No abstract available.
Is extended release naltrexone superior to buprenorphine-naloxone to reduce drinking among outpatients receiving treatment for opioid use disorder? A secondary analysis of the CTN X:BOT trial.
Roache JD, Pavlicova M, Campbell A, Choo TH, Peavy M, Kermack AS, Nunes EV Jr, Rotrosen J. Roache JD, et al. Among authors: choo th. Alcohol Clin Exp Res. 2021 Dec;45(12):2569-2578. doi: 10.1111/acer.14729. Epub 2021 Nov 23. Alcohol Clin Exp Res. 2021. PMID: 34698397 Free PMC article.
75 results